Capital Fund Management (CFM)’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Capital Fund Management (CFM)’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-57,912	Closed	-$269K	–	1881
2021 Q4	$269K	Buy	+57,912	New	+$360K	﹤0.01%	1530
2021 Q3	–	Sell	-329,434	Closed	-$3.19M	–	1854
2021 Q2	$3.19M	Buy	+329,434	New	+$2.62M	0.03%	755
2016 Q1	–	Sell	-39,196	Closed	-$341K	–	1933
2015 Q4	$341K	Buy	+39,196	New	+$331K	﹤0.01%	1257

Other funds holding SRNE

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return

Capital Fund Management (CFM)'s SRNE Position: Q1 2022 in Review

Capital Fund Management (CFM) sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2022, closing a stake of 57,912 shares — an estimated $269K sold.

Capital Fund Management (CFM) first reported a position in SRNE in Q4 2015 and held it in 3 quarters. The position peaked at $3.19M in Q2 2021. 235 funds tracked by Wall St. Rank hold SRNE as of Q1 2022.

Capital Fund Management (CFM) reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2022 after selling out during the quarter.
Capital Fund Management (CFM) sold 57,912 Sorrento Therapeutics, Inc. shares in Q1 2022, an estimated $269K.
Capital Fund Management (CFM) first reported a position in Sorrento Therapeutics, Inc. in Q4 2015 and held it in 3 quarters.
Capital Fund Management (CFM)'s Sorrento Therapeutics, Inc. position peaked at $3.19M in Q2 2021.
235 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2022.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2022, filed 12 May 2022.